Caitong International Asset Management’s scPharmaceuticals SCPH Stock Holding History

Caitong International Asset Management’s Portfolio SCPH Stock Details SCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-218	Closed	-$1.24K	–	2321
2025 Q3	$1.24K	Sell	218 -3	-1%	-$15	﹤0.01%	1437
2025 Q2	$842	Buy	+221	New	+$686	﹤0.01%	1611
2025 Q1	–	Sell	-267	Closed	-$945	–	2485
2024 Q4	$945	Buy	+267	New	+$1.02K	﹤0.01%	1342

Caitong International Asset Management's SCPH Position: Q4 2025 in Review

Caitong International Asset Management sold out of scPharmaceuticals (SCPH) in Q4 2025, closing a stake of 218 shares — an estimated $1.24K sold.

Caitong International Asset Management first reported a position in SCPH in Q4 2024 and held it in 3 quarters. The position peaked at $1.24K in Q3 2025. 0 funds tracked by Wall St. Rank hold SCPH as of Q4 2025.

Caitong International Asset Management reported no remaining scPharmaceuticals position as of Q4 2025 after selling out during the quarter.
Caitong International Asset Management sold 218 scPharmaceuticals shares in Q4 2025, an estimated $1.24K.
Caitong International Asset Management first reported a position in scPharmaceuticals in Q4 2024 and held it in 3 quarters.
Caitong International Asset Management's scPharmaceuticals position peaked at $1.24K in Q3 2025.
0 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2025.

Based on Caitong International Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.